GOLDMAN SACHS GROUP INC - TONIX PHARMACEUTICALS HLDG C ownership

Back to all holdings Add to watchlist

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 88 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$98,000
-55.3%
424,848
-30.6%
0.00%–
Q4 2021$219,000
-41.0%
612,442
-0.6%
0.00%–
Q3 2021$371,000
+902.7%
616,135
+1755.8%
0.00%–
Q2 2021$37,000
-88.5%
33,201
-86.8%
0.00%–
Q1 2021$322,000–251,740–0.00%–
 Download
Other shareholders

There were no reported owners of TONIX PHARMACEUTICALS HLDG C in Q4 2021.

NameSharesValueWeighting ↓
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders